Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The organic calcium antagonist verapamil in doses of 320-480 mg/day reduced manic symptomatology in seven of eight patients manifesting a manic or schizomanic syndrome in a placebo-controlled, double-blind study. The delayed onset of antimanic effects parallels the action of lithium in acute mania. Common pharmacological profiles of lithium, certain anticonvulsants, and neuroleptics with regard to calcium dependent processes are discussed.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on